Rice University
Feb 20, 2018
CRISPR to cure sickle cell; FDA rejected; Stem cells use; Celgene spinoff
Rice University researchers tested CRISPR to cure sickle cell, now preparing for upcoming challenges A team of Researchers led by Rice University has recently tested CRISPR to correct the sickle cell mutation in up to 40% of the total stem cell samples taken from affected patients. Although the results are quite pro...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
